03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
As regular readers of our blog will already know, the issue of whether Title VII prohibits employmen...
Read More >
Starting January 1, 2020, the new Dutch Balanced Labor Market Act (Wet arbeidsmarkt in balans, WAB) ...
Read More >
The United States Bankruptcy Court for the District of Puerto Rico recently rejected a defendant’s ...
Read More >
The NLRB has announced long-awaited major modifications to its controversial 2014 election rule. The...
Read More >
Recent reports of abuse in nursing homes are not only disturbing; they also shed light on the diffic...
Read More >
As many of you know, an employer does not have to offer COBRA health insurance coverage to an employ...
Read More >